Overview
Sgltr Tablets 100 mg contain Remogliflozin Etabonate, an oral antidiabetic agent belonging to the SGLT2 (sodium-glucose co-transporter-2) inhibitor class. It is used to manage type 2 diabetes mellitus by promoting the excretion of excess glucose through urine, thereby lowering blood sugar levels. Sgltr also supports weight loss and may contribute to blood pressure reduction, making it a beneficial choice for patients with coexisting metabolic conditions.





